Upgrade to SI Premium - Free Trial

Travere Therapeutics (TVTX) PT Raised to $56 at Canaccord

April 14, 2026 7:00 AM
Canaccord analyst Ed Nash raised ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change